The sensitivity and specificity of each of the screening options were:
PSA3 alone (systematic), 71.9% & 80.4%;
PSA3 alone (tailored), 64.3% & 90.5%;
PSA4 alone (systematic), 64.3% & 87.5%;
PSA4 alone (tailored), 60.2% & 91.5%;
DRE + PSA4 (systematic), 80.7% & 79.1%;
DRE + PSA4 (tailored), 72.5% & 88.4%;
AgePSA alone (systematic), 58.5% & 90.9%;
AgePSA alone (tailored), 56.1% & 93.1%;
AgePSA + DRE (systematic), 77.8% & 82.1%;
and AgePSA + DRE (tailored), 69.0% & 88.6%